Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed Nov 12, 2020 · 10-Q · 43 days after period end · 0001493152-20-021083
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$3.07M | -$863.52K | -$852.82K | -$204.41K |
| EPS Diluted | -$0.55 | -$0.16 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 12, 2020 · 43 d after period end
